-
The Capitol Forum says EU competition chief Margrethe Vestager is on board with the remedies. -
The group reports an 86% CoR in its last trading update as a listed entity.
-
In 2020 the market fell to “near paralysis” in the early stages of the pandemic, before rebounding strongly.
-
The deal could be signed later this week or at the weekend, sources said.
-
CEO Talbir Bains founded the business in 2017 with backing from the market’s largest ILS manager.
-
The acquisition is the third this year for the Lovell Minnick-backed acquirer.
-
The regulator had previously set a 27 July deadline after the merger partners offered divestments to secure regulatory approval.
-
The intermediary has been expanding its presence in the Australian market considerably since the acquisition of Wesfarmer’s insurance business for $933mn 2014.
-
CEO Greg Case says the broking union offers greater opportunities than when the deal was first announced.
-
Incoming regulatory changes means there is high growth potential for the nuclear risk market.
-
With a sale of the remedy assets to AJG not yet agreed, the firms will have to choose their words carefully this week.
-
Chairman Paul Folino said he expected the deal to be completed over the second quarter.
